Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Rongjia Su"'
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe key biochemical feature of malignant tumor is the conversion of energy metabolism from oxidative phosphorylation to glycolysis, which provides sufficient capacity and raw materials for tumor cell rapid growth. Our study aims to construc
Externí odkaz:
https://doaj.org/article/1791bdd7223d4ab58b36150ac618e550
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Ovarian cancer is the leading cause of death among gynecological malignancies. Immunotherapy has demonstrated potential effects in ovarian cancer. However, few studies on immune-related prognostic signatures in ovarian cancer have
Externí odkaz:
https://doaj.org/article/ed1ff802cf9f4e2e8004c30bf5120441
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundCervical cancer is the fourth most frequent gynecological malignancy across the world. Immunotherapies have proved to improve prognosis of cervical cancer. However, few studies on immune-related prognostic signature had been reported in cer
Externí odkaz:
https://doaj.org/article/7eb51a6fb45a4bc6845a31888bfff8df
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Background: The homologous recombination (HR) pathway defects in cancers induced abrogation of cell cycle checkpoints, resulting in the accumulation of DNA damage, mitotic catastrophe, and cell death. Cancers with BRCA1/2 loss and other accumulation
Externí odkaz:
https://doaj.org/article/8d61666b6e0e4d04abaffd37e16ba75f
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2021)
BackgroundThe overall cumulative live birth rate (CLBR) of poor ovarian responders (POR) is extremely low. Minimal ovarian stimulation (MOS) provides a relatively realistic solution for ovarian stimulation in POR. Our study aimed to investigate wheth
Externí odkaz:
https://doaj.org/article/5e5d1ec7a4ef4d62a48cb909549591ec
Publikováno v:
Journal of Business Economics and Management, Vol 21, Iss 4 (2020)
This paper investigates the differential effects of corporate social responsibility (CSR) dimensions on corporate financial performance (CFP) across sectors in China. This research uses a unique data set provided by China Stock Market and Accounting
Externí odkaz:
https://doaj.org/article/456383b4eaed4431adcc1a1d6647636b
Publikováno v:
The Journal of Gene Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad3869c2e84e3ecbf28973668df1dc01
https://doi.org/10.1002/jgm.3504
https://doi.org/10.1002/jgm.3504
Publikováno v:
Asian Business & Management.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4474993898be2fc4e910baa929d54f5c
https://doi.org/10.1057/s41291-022-00211-4
https://doi.org/10.1057/s41291-022-00211-4
Publikováno v:
Frontiers in Molecular Biosciences, Vol 8 (2021)
Frontiers in Molecular Biosciences
Frontiers in Molecular Biosciences
Background: The homologous recombination (HR) pathway defects in cancers induced abrogation of cell cycle checkpoints, resulting in the accumulation of DNA damage, mitotic catastrophe, and cell death. Cancers with BRCA1/2 loss and other accumulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::284039cedc38f76fdc65c0ce26f3af94
https://www.frontiersin.org/articles/10.3389/fmolb.2021.762741/full
https://www.frontiersin.org/articles/10.3389/fmolb.2021.762741/full
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Background Ovarian cancer is the leading cause of death among gynecological malignancies. Immunotherapy has demonstrated potential effects in ovarian cancer. However, few studies on immune-related prognostic signatures in ovarian cancer have been rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::089074eb7d11822af5e59042088a2313
http://europepmc.org/articles/PMC8404317
http://europepmc.org/articles/PMC8404317